MENU

Google partnership for tiny CGMs
Published on August 13, 2015

Leading diabetes device manufacturer DexCom has signed a deal with Google Life Sciences to build miniature continuous glucose monitors (CGMs). The companies will jointly design the next-generation CGMs, which will be smaller than a 5 cent coin and will combine Google’s miniaturisation expertise with DexCom’s cutting-edge glucose sensor technology. The first stage of development under […]

Share
Insulin pill shows promise as T1D vaccine
Published on July 17, 2015

A JDRF-supported clinical trial in Germany has shown that a simple insulin pill may be able to prevent type 1 diabetes. When the pills were given to children at high-risk of developing T1D, their immune systems showed signs of becoming more tolerant to insulin. This tolerance could prevent the immune system from attacking the insulin-producing […]

Share
Feel In Charge of Your Diabetes Online!
Published on July 1, 2015

Our friends at the Black Dog Institute are running an online trial for young Australians with T1D. Associate Professor Judy Proudfoot explains the trial, and how you can get involved. My experience is in the design, development and evaluation of digital programs for improving mental health and wellbeing. As the Head of eHealth at the Black […]

Share
3D-printing a T1D-free future
Published on June 4, 2015

3D-printing technology has been providing hope to the medical community over the past few years with developments like the printing of prosthetic limbs, or even bone for skull fractures. Now, researchers have found a way to 3D-print a potential cure for type 1 diabetes, in the form of a protective structure for islet cells.

Share
Researchers discover that size matters…
Published on May 26, 2015

…the size and shape of capsules used in islet cell encapsulation therapy that is! Islet cell encapsulation is an exciting branch of type 1 diabetes research that is providing real potential for a future ‘cure’ for all people with type 1 diabetes. In this research, insulin-producing cells are protected by a ‘capsule’ that is implanted […]

Share

The Australian-first Type 1 Diabetes Clinical Research Resource Map (the Resource Map), published today by JDRF Australia, is a first ever snapshot analysis of the type 1 diabetes clinical research landscape in Australia. Incorporating data collected in interviews with leading Australian clinical researchers, the Resource Map has identified five key areas in the research development […]

Share
Could fish oil help T1D complications?
Published on May 12, 2015

Researchers from the US have found that taking fish oil every day was able to slow the development of T1D-related nerve damage in mice, and even reversed the damage that had already occurred. In the study, mice had their insulin-producing beta cells chemically destroyed to model type 1 diabetes, and were divided into different dietary […]

Share
New discovered pathway keeps immune system in check
Published on May 1, 2015

Discovery of an immune system molecule could help to boost the immunity of people with a predisposition to type 1 diabetes. JDRF researchers found that high levels of this molecule known as PEPITEM could restore normal immune T cell function and therefore reverse or stop the T1D autoimmune attack. These researchers identified that PEPITEM controls […]

Share
Australia’s largest study on the causes of T1D receives $8m boost
Published on April 27, 2015

JDRF Australia has today announced that a new $8 million partnership with The Leona M. and Harry B. Helmsley Charitable Trust, for investment into the Australian Type 1 Diabetes Clinical Research Network (T1DCRN), a JDRF Australia initiative. This partnership will support Environmental Determinants of Islet Autoimmunity (ENDIA), a ground-breaking study to help solve the mystery […]

Share